Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3397 | 1917 | 31.9 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
708 | 12194 | CALCIUM ANTAGONISTS//AMLODIPINE//ISRADIPINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SR 33557 | Author keyword | 12 | 86% | 0% | 6 |
2 | SR33805 | Author keyword | 6 | 100% | 0% | 4 |
3 | H 3PN200 110 | Author keyword | 4 | 75% | 0% | 3 |
4 | H 3 AZIDOPINE | Author keyword | 3 | 100% | 0% | 3 |
5 | BAY K 8644 | Author keyword | 3 | 12% | 1% | 24 |
6 | BASIC MED SCI BIOPHYS | Address | 2 | 67% | 0% | 2 |
7 | CGP 28392 | Author keyword | 2 | 67% | 0% | 2 |
8 | NEGATIVE CHRONOTROPIC ACTION | Author keyword | 2 | 67% | 0% | 2 |
9 | NIMODIPINE BINDING | Author keyword | 2 | 67% | 0% | 2 |
10 | STATE DEPENDENT INTERACTIONS | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SR 33557 | 12 | 86% | 0% | 6 | Search SR+33557 | Search SR+33557 |
2 | SR33805 | 6 | 100% | 0% | 4 | Search SR33805 | Search SR33805 |
3 | H 3PN200 110 | 4 | 75% | 0% | 3 | Search H+3PN200+110 | Search H+3PN200+110 |
4 | H 3 AZIDOPINE | 3 | 100% | 0% | 3 | Search H+3+AZIDOPINE | Search H+3+AZIDOPINE |
5 | BAY K 8644 | 3 | 12% | 1% | 24 | Search BAY+K+8644 | Search BAY+K+8644 |
6 | CGP 28392 | 2 | 67% | 0% | 2 | Search CGP+28392 | Search CGP+28392 |
7 | NEGATIVE CHRONOTROPIC ACTION | 2 | 67% | 0% | 2 | Search NEGATIVE+CHRONOTROPIC+ACTION | Search NEGATIVE+CHRONOTROPIC+ACTION |
8 | NIMODIPINE BINDING | 2 | 67% | 0% | 2 | Search NIMODIPINE+BINDING | Search NIMODIPINE+BINDING |
9 | STATE DEPENDENT INTERACTIONS | 2 | 67% | 0% | 2 | Search STATE+DEPENDENT+INTERACTIONS | Search STATE+DEPENDENT+INTERACTIONS |
10 | DIHYDROPYRIDINE BINDING | 2 | 33% | 0% | 5 | Search DIHYDROPYRIDINE+BINDING | Search DIHYDROPYRIDINE+BINDING |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SR 33557 | 19 | 71% | 1% | 15 |
2 | BAY K 8644 | 15 | 25% | 3% | 51 |
3 | NITRENDIPINE | 10 | 15% | 3% | 59 |
4 | H 3 PN 200 110 | 9 | 83% | 0% | 5 |
5 | GENERAL ANESTHETIC POTENCY | 8 | 60% | 0% | 9 |
6 | H 3NITRENDIPINE | 8 | 100% | 0% | 5 |
7 | HEART SARCOLEMMAL MEMBRANES | 8 | 100% | 0% | 5 |
8 | CA 2 CHANNELS | 8 | 12% | 3% | 62 |
9 | FPL 64176 | 7 | 50% | 1% | 10 |
10 | FAST PHASE | 7 | 57% | 0% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
RECEPTOR-SITES FOR CA2+ CHANNEL ANTAGONISTS | 1992 | 310 | 33 | 48% |
CALCIUM CHANNELS - MOLECULAR PHARMACOLOGY, STRUCTURE AND REGULATION | 1988 | 370 | 272 | 44% |
MOLECULAR-PROPERTIES OF DIHYDROPYRIDINE-SENSITIVE CALCIUM CHANNELS IN SKELETAL-MUSCLE | 1988 | 202 | 41 | 76% |
CLASSIFICATION OF CALCIUM CHANNELS AND THE SITES OF ACTION OF DRUGS MODIFYING CHANNEL FUNCTION | 1992 | 251 | 108 | 41% |
1,4-DIHYDROPYRIDINE ACTIVATORS AND ANTAGONISTS - STRUCTURAL AND FUNCTIONAL DISTINCTIONS | 1989 | 104 | 25 | 88% |
Regulation of neuronal voltage-gated calcium channels by ethanol | 1999 | 78 | 65 | 37% |
Calcium channel blockers in psychiatric disorders: A review of the literature | 1999 | 21 | 41 | 78% |
WIDENING POTENTIAL FOR CA-2+ ANTAGONISTS - NON-L-TYPE CA-2+ CHANNEL INTERACTION | 1990 | 134 | 27 | 44% |
CALCIUM ANTAGONISM AND CALCIUM ENTRY BLOCKADE | 1986 | 1089 | 748 | 25% |
OPEN TRIAL OF A CALCIUM-ANTAGONIST, NIMODIPINE, IN ACUTE MANIA | 1990 | 61 | 5 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BASIC MED SCI BIOPHYS | 2 | 67% | 0.1% | 2 |
2 | DRUG DEPENDENCE UNIT | 2 | 21% | 0.4% | 7 |
3 | PROGRAMS NEUROSCI BIOMED SCI | 1 | 33% | 0.1% | 2 |
4 | ELE OPHYSIOL PHARMACOL CELLULAI | 1 | 50% | 0.1% | 1 |
5 | HLTH RADIOL | 1 | 50% | 0.1% | 1 |
6 | MED D79 | 1 | 50% | 0.1% | 1 |
7 | S TEXAS ADDICT TECHNOL | 1 | 50% | 0.1% | 1 |
8 | UNIDADE PSICOFIS | 1 | 50% | 0.1% | 1 |
9 | PHARM BIOCHEM PHARMACOL | 1 | 29% | 0.1% | 2 |
10 | BIOFIS MUSCULO | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000184424 | OMEGA CONOTOXIN GVIA//OMEGA CONOTOXIN//OMEGA CONOTOXIN BINDING |
2 | 0.0000181690 | DUODENAL DISTENSION//KATEDRA FIZJOL BIOCHEM FARMAKOL TOKSYKOL//EXPT CLIN PHYSIOPHARMACOL |
3 | 0.0000126141 | EXPTL EPILEPSIEFOR//EXPERIMENTAL EPILEPSY MODELS//MODEL NERVOUS SYSTEM |
4 | 0.0000117083 | CALCIUM SIGNALS//CALCIUM CHANNEL//PROGRAM MOL CELLULAR SYST PHYSIOL |
5 | 0.0000102823 | NIMODIPINE//EMOPAMIL//TC 81 |
6 | 0.0000085582 | MUSCULAR DYSGENESIS//POTASSIUM CONTRACTURES//INTRAMEMBRANE CHARGE MOVEMENT |
7 | 0.0000085290 | META NISOLDIPINE//VOLTAGE ACTIVATED//M NISOLDIPINE |
8 | 0.0000084991 | BEPRIDIL//CAS 117241 46 0//REVUE DE MEDECINE |
9 | 0.0000079265 | EYELID PRESSURE//MULTIEXPONENTIAL FITTING//PROPOFOL EMULSION |
10 | 0.0000079126 | CA2 ANTAGONISTIC ACTION//INNOVAT PATHOPHYSIOL GRP//RAT PHRENIC NERVE |